![Zydus Lifesciences Share Price Zydus Lifesciences Share Price](https://images.5paisa.com/MarketIcons/ZYDUSLIFE.png)
Zydus Lifesciences Share Price
- Advice
- Hold
Start SIP in Zydus Lifesciences
Start SIPZydus Lifesciences Performance
Day Range
- Low 1,097
- High 1,120
52 Week Range
- Low 568
- High 1,324
- Open Price1,119
- Previous Close1,115
- Volume1307399
Zydus Lifesciences F&O
Zydus Lifesciences Investment Rating
-
Master Rating:
-
Zydus Lifesciences has an operating revenue of Rs. 20,615.30 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 25% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 17% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around -4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 4,035 | 3,173 | 2,371 | 2,159 | 2,956 | 2,437 |
Operating Expenses Qtr Cr | 1,787 | 1,763 | 1,672 | 1,510 | 1,815 | 1,807 |
Operating Profit Qtr Cr | 2,373 | 1,569 | 699 | 649 | 1,141 | 773 |
Depreciation Qtr Cr | 131 | 131 | 128 | 125 | 121 | 120 |
Interest Qtr Cr | 115 | 106 | 104 | 91 | 90 | 85 |
Tax Qtr Cr | 533 | 280 | 124 | 163 | 232 | 124 |
Net Profit Qtr Cr | 1,701 | 1,405 | 450 | 805 | 781 | 491 |
Zydus Lifesciences Technicals
EMA & SMA
![pointer pointer](https://cdn-static.trendlyne.com/static/img/brokerwebview/pointer.png)
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹1,149.50
- 50 Day
- ₹1,149.55
- 100 Day
- ₹1,094.97
- 200 Day
- ₹978.17
- 20 Day
- ₹1,162.32
- 50 Day
- ₹1,171.10
- 100 Day
- ₹1,097.51
- 200 Day
- ₹950.36
Zydus Lifesciences Resistance and Support
Resistance | |
---|---|
First Resistance | 1,114.27 |
Second Resistance | 1,128.53 |
Third Resistance | 1,137.07 |
RSI | 37.37 |
MFI | 69.75 |
MACD Single Line | -14.29 |
MACD | -22.00 |
Support | |
---|---|
First Support | 1,091.47 |
Second Support | 1,082.93 |
Third Supoort | 1,068.67 |
Zydus Lifesciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 1,328,935 | 81,623,188 | 61.42 |
Week | 1,929,779 | 124,316,350 | 64.42 |
1 Month | 4,448,386 | 262,276,867 | 58.96 |
6 Month | 2,122,645 | 113,879,902 | 53.65 |
Zydus Lifesciences Result Highlights
Zydus Lifesciences Synopsis
NSE-Medical-Generic Drugs
Zydus Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 10818.70 Cr. and Equity Capital is Rs. 100.60 Cr. for the Year ended 31/03/2024. Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878.Market Cap | 110,686 |
Sales | 12,023 |
Shares in Float | 25.16 |
No of funds | 383 |
Yield | 0.27 |
Book Value | 7.04 |
U/D Vol ratio | 0.8 |
LTDebt / Equity | 35 |
Alpha | 0.15 |
Beta | 0.73 |
Zydus Lifesciences Shareholding Pattern
Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|
Promoters | 74.98% | 74.98% | 74.98% | 74.98% |
Mutual Funds | 7.24% | 6.71% | 6.99% | 5.94% |
Insurance Companies | 5.22% | 5.74% | 5.8% | 6.86% |
Foreign Portfolio Investors | 5.59% | 5.72% | 4.99% | 4.85% |
Financial Institutions/ Banks | 0.01% | |||
Individual Investors | 5.37% | 5.28% | 5.6% | 5.66% |
Others | 1.6% | 1.57% | 1.63% | 1.71% |
Zydus Lifesciences Management
Name | Designation |
---|---|
Mr. Pankaj R Patel | Chairman |
Dr. Sharvil P Patel | Managing Director |
Mr. Ganesh N Nayak | Executive Director |
Mr. Mukesh M Patel | Non Executive Director |
Mr. Bhadresh K Shah | Independent Director |
Ms. Apurva S Diwanji | Independent Director |
Mr. Monappa Arun Akhil | Independent Director |
Mrs. Upasana Konidela | Independent Woman Director |
Ms. Shelina P Parikh | Independent Woman Director |
Zydus Lifesciences Forecast
Price Estimates
Zydus Lifesciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-08-09 | Quarterly Results | |
2024-05-17 | Audited Results & Final Dividend | |
2024-02-09 | Quarterly Results & Buy Back of shares | |
2023-11-07 | Quarterly Results | |
2023-08-11 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2024-07-26 | FINAL | Rs.3.00 per share(300%)Final Dividend |
2023-07-28 | FINAL | Rs.6.00 per share(600%)Final Dividend |
2022-07-29 | FINAL | Rs.2.50 per share(250%)Final Dividend |
About Zydus Lifesciences
Zydus Lifesciences FAQs
What is Share Price of Zydus Lifesciences ?
Zydus Lifesciences share price is ₹1,100 As on 08 September, 2024 | 07:09
What is the Market Cap of Zydus Lifesciences ?
The Market Cap of Zydus Lifesciences is ₹110685.7 Cr As on 08 September, 2024 | 07:09
What is the P/E ratio of Zydus Lifesciences ?
The P/E ratio of Zydus Lifesciences is 25.6 As on 08 September, 2024 | 07:09
What is the PB ratio of Zydus Lifesciences ?
The PB ratio of Zydus Lifesciences is 5 As on 08 September, 2024 | 07:09
What were the company's most recent reported sales and net income?
Zydus Lifesciences Ltd. recorded a net income of INR 15,265.20 crores in FY22
What is the future of the company's shares?
Zydus Lifesciences Ltd. stock is a good option for long-term investment since the shares are ripe for buying right now.
How to buy shares of Zydus Lifesciences Ltd.?
The company's shares can be bought online opening a demat account with 5paisa and verifying the KYC documents. You can also open demat account via our mobile app.